The Department shall report to the committee of the Council having jurisdiction over health and human services matters on or before January 1, 2005 and on or before July 1, 2005 on the assessment of fees on manufacturers and labelers of prescription drugs.
(May 18, 2004, D.C. Law 15-164, § 308, 51 DCR 3688.)
Structure District of Columbia Code
Chapter 8A - Affordability of Prescription Drugs — AccessRx Program
Subchapter III - Full Disclosure of Prescription Drug Marketing Costs
§ 48–833.01. Requirement to disclose prescription drug marketing costs
§ 48–833.02. Manner of reporting
§ 48–833.03. Content of annual report by manufacturer or labeler
§ 48–833.04. Department reports